Steris | STE - Equity Capital And Reserves


Steris reported $7.21B in Equity Capital and Reserves for its fiscal quarter ending in June of 2026.





Equity Capital And Reserves Change Date
3M USD 4.13B 1.18B Sep/2026
Accuray USD 53.42M 8.45M Dec/2025
Baxter International USD 6.5B 296M Sep/2026
Becton, Dickinson and Co. USD 24.42B 283M Jun/2026
Boston Scientific USD 25.63B 700M Sep/2026
CONMED USD 1.06B 18.53M Sep/2026
Cooper Companies USD 8.33B 89.1M Jun/2026
Dexcom USD 2.54B 86M Sep/2026
Ecolab USD 10.42B 368.4M Sep/2026
Edwards Lifesciences USD 10.86B 243.1M Sep/2026
Fortive USD 5.95B 122.2M Sep/2026
Getinge SEK 30.94B 2.06B Jun/2026
Globus Medical USD 4.8B 27.65M Sep/2026
Haemonetics USD 898.5M 61.4M Sep/2026
Idexx Laboratories USD 1.87B 256.6M Sep/2026
Inogen USD 197.18M 2.32M Sep/2025
Insulet USD 1.58B 156.9M Sep/2026
Integra LifeSciences USD 1.07B 23.24M Sep/2026
Intuitive Surgical USD 15.99B 2.18B Sep/2026
J&J USD 81.53B 3.44B Sep/2026
Olympus JPY 755.41B 7.51B Sep/2026
Orthofix International USD 429.57M 387K Sep/2026
Owens Minor USD -568.23M 17.29M Sep/2026
ResMed USD 5.95B 637.7M Sep/2026
Steris USD 7.21B 23.1M Jun/2026
Stryker USD 23.99B 1.01B Jun/2026
Tandem Diabetes Care USD 135.09M 4.7M Sep/2026
Teleflex USD 3.49B 589.18M Sep/2026
Thermo Fisher Scientific USD 54.76B 2.08B Sep/2026
Zimmer Biomet Holdings USD 12.72B 83.1M Sep/2026